There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 6 | 21 | 2001.8 |
| 1 | 8 | 2001.7 |
| 1 | 6 | 2001.6 |
| 3 | 10 | 2001.5 |
| 1 | 1 | 2001.4 |
| Ask | Qty | Orders |
|---|---|---|
| 2004.6 | 1 | 7 |
| 2004.8 | 3 | 13 |
| 2005 | 3 | 1096 |
| 2005.1 | 1 | 5 |
| 2005.4 | 1 | 4 |
Annual Revenue,rose 8.73%, in the last year to ₹9,820.78 Cr. Its sector's average revenue growth for the last fiscal year was 12.19%.Annual Net Profit,rose 54.69% in the last year to ₹1,141.12 Cr. Its sector's average net profit growth for the last fiscal year was 1.94%.Quarterly Revenue,rose 20.76% YoY to ₹2,813.36 Cr. Its sector's average revenue growth YoY for the quarter was 15.88%.
Ipca Laboratories Ltd has delivered a 82.78% absolute return over the past 5 years, equivalent to a CAGR of 12.82% per annum. The stock was priced at ₹1,078.89 in Nov 2021 and has risen to ₹1,972.00 as of 04 Nov 2026. An investment of ₹1,00,000 in Ipca Laboratories Ltd five years ago would be worth ₹1,82,780.00 today.
Yes,Ipca Laboratories Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 18.00 per share between FY2022 and FY2026, with the most recent dividend of ₹6.00 per share for May 26, with an ex-dividend date of 07 Aug 2026. At the current market price of ₹1,972.00, the trailing dividend yield of Ipca Laboratories Ltd stands at 6.00%.
Ipca Laboratories Ltd has delivered a return of 15.07% over the last 3 months. The stock was trading at ₹1,694.70 on 04 Aug 2026 and is currently at ₹1,972.00 as of 04 Nov 2026, reflecting a Gain of ₹277.30 per share over this period.
The intraday low for Ipca Laboratories Ltd on the NSE today was ₹1,955.00. The stock's 52-week low stands at ₹1,276.10, recorded on 07 Nov 2025. Today's low is 53.20% above the 52-week low, indicating the stock is trading well above its yearly lows.
As of 04 Nov 2026, the share price of Ipca Laboratories Ltd is ₹1,972.00 on the NSE and ₹1,972.60 on the BSE. The stock opened at ₹1,955.00, touched a high of ₹1,995.00 and a low of ₹1,955.00 during today's session.
Over the last 6 months, Ipca Laboratories Ltd has given a return of 27.46%. The stock was priced at ₹1,530.00 on 04 May 2026 and has Rise to ₹1,972.00 as of 04 Nov 2026, a change of ₹442.00 per share.
The intraday high for Ipca Laboratories Ltd on the NSE today (04 Nov 2026) was ₹1,995.00. This compares to the 52-week high of ₹2,038.00 recorded on 18 Sep 2026. Today's high was -2.11% below the 52-week high.
Ipca Laboratories Ltd has delivered 50.61% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,038.00 on 18 Sep 2026 and a 52-week low of ₹1,276.10 on 07 Nov 2025. It is currently trading at ₹1,972.00 as of 04 Nov 2026.
The all-time high (ATH) for Ipca Laboratories Ltd was ₹2,009.60, recorded on 18 Sep 2026. At the current price of ₹1,972.00, the stock is trading 1.87% below its all-time high. The all-time low recorded was ₹104.60 on 07 Jan 2010.
For Q1 FY27, Ipca Laboratories Ltd reported: Revenue (Net Sales): ₹21192.40 Cr - Up 16.80% year-on-year from ₹18143.50 Cr in Q4 FY26. Net Income (PAT): ₹3732.90 Cr - Up 42.32% year-on-year from ₹2622.90 Cr in Q4 FY26.
